Buonarati M H, Roper M, Morris C J, Happe J A, Knize M G, Felton J S
Biomedical Sciences Division, Lawrence Livermore National, Laboratory, Livermore, CA 94551.
Carcinogenesis. 1992 Apr;13(4):621-7. doi: 10.1093/carcin/13.4.621.
The metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP), a heterocyclic amine carcinogen detected in cooked meats, was investigated in mice. In 3-methylcholanthrene-induced mice administered 0.1, 1.0 and 10 mg/kg [14C]PhIP (i.p.), urinary and fecal excretion over 24 h accounted for 16% and 42-56% of the dose respectively. Urinary excretion of unchanged parent compound accounted for only 0.5-0.8% of the administered dose. At all doses, the major urinary metabolite was identified as 4'-(2-amino-1-methylimidazo[4,5-b]pyrid-6-yl)phenyl sulfate and this metabolite comprised approximately 5% of the dose. Uninduced mice excreted greater than 13% of a 10 mg/kg dose as the sulfate conjugate. Urinary excretion of both 2-amino-1-methyl-6-(4'-hydroxy)-phenylimidazo[4,5-b]pyridine (4'-hydroxy-PhIP) and a glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (N-hydroxy-PhIP) was also higher (4-fold) in uninduced versus induced mice. The decreased urinary excretion of P450-derived metabolites via induction contrasted with increased metabolite formation by hepatic microsomal preparations. 4'-Hydroxy-PhIP and N-hydroxy-PhIP were produced in amounts nearly 7- and 3-fold higher respectively by induced versus uninduced microsomal incubations at 50 microM [3H]PhIP. At concentrations less than 10 microM, PhIP was almost exclusively converted by the induced preparations to an unidentified metabolite that was not retained by the C18 column. This metabolite, which also was formed in incubations with either 4'-hydroxy-PhIP or N-hydroxy-PhIP, was produced by microsomes from uninduced animals at a much slower rate. Covalent binding to microsomal protein in incubations with [3H]PhIP was concentration-dependent and 2- to 4-fold higher in induced than uninduced preparations. Covalent binding in liver and kidney of induced mice administered [14C]PhIP was dose dependent. At 10 mg/kg PhIP, adducts were produced at 1.7-fold higher levels in livers of induced versus uninduced mice, but renal binding was higher in uninduced animals. These studies indicate the importance of cytochrome P450 and other xenobiotic enzymes in the metabolism, disposition and activation of PhIP.
对熟肉中检测到的杂环胺致癌物2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)在小鼠体内的代谢情况进行了研究。给经3-甲基胆蒽诱导的小鼠腹腔注射0.1、1.0和10mg/kg的[¹⁴C]PhIP,24小时内尿液和粪便排泄量分别占给药剂量的16%和42%-56%。尿液中未变化的母体化合物排泄量仅占给药剂量的0.5%-0.8%。在所有剂量下,主要的尿液代谢物被鉴定为4'-(2-氨基-1-甲基咪唑并[4,5-b]吡啶-6-基)苯硫酸盐,该代谢物约占给药剂量的5%。未诱导的小鼠排泄出的10mg/kg剂量中,大于13%以硫酸盐结合物形式存在。未诱导小鼠尿液中2-氨基-1-甲基-6-(4'-羟基)-苯基咪唑并[4,5-b]吡啶(4'-羟基-PhIP)和2-羟基氨基-1-甲基-6-苯基-咪唑并[4,5-b]吡啶(N-羟基-PhIP)的葡糖醛酸结合物排泄量也比诱导小鼠高(4倍)。通过诱导使细胞色素P450衍生代谢物的尿液排泄减少,这与肝微粒体制剂中代谢物形成增加形成对比。在50μM[³H]PhIP条件下,诱导微粒体孵育产生的4'-羟基-PhIP和N-羟基-PhIP量分别比未诱导的高近7倍和3倍。在浓度低于10μM时,PhIP几乎完全被诱导制剂转化为一种未鉴定的代谢物,该代谢物不被C18柱保留。这种代谢物在与4'-羟基-PhIP或N-羟基-PhIP孵育时也会形成,未诱导动物的微粒体产生该代谢物的速度要慢得多。在与[³H]PhIP孵育时,与微粒体蛋白的共价结合呈浓度依赖性,诱导制剂中的共价结合比未诱导制剂高2至4倍。给经[¹⁴C]PhIP处理的诱导小鼠肝脏和肾脏中的共价结合呈剂量依赖性。在10mg/kg PhIP剂量下,诱导小鼠肝脏中加合物的产生水平比未诱导小鼠高1.7倍,但未诱导动物肾脏中的结合更高。这些研究表明细胞色素P450和其他外源生物酶在PhIP的代谢、处置和活化中的重要性。